Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LYEL - Lyell Immunopharma Inc


IEX Last Trade
1.455
-0.005   -0.344%

Share volume: 1,025,531
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1.46
-0.01
-0.34%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-04 2022-11-08 2023-02-28 2023-05-04 2023-08-08 2023-11-07 2024-02-28 2024-05-06
Total revenue 35.741 M 3.000 K 48.386 M 65.000 K 27.000 K 25.000 K 13.000 K 3.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 35.741 M 3.000 K 48.386 M 65.000 K 27.000 K 25.000 K 13.000 K 3.000 K
    -99.99% 1,612,766.67% -99.87% -58.46% -7.41% -48.00% -76.92%  
Operating expenses 74.173 M 67.691 M 64.380 M 63.909 M 66.501 M 59.356 M 60.162 M 56.668 M
Selling general and admin 30.454 M 26.084 M 26.348 M 19.279 M 19.030 M 15.507 M 13.167 M 13.494 M
Research and development 43.719 M 41.607 M 38.032 M 44.630 M 47.471 M 43.849 M 46.995 M 43.174 M
Total expenses 73.002 M 66.440 M 63.170 M 62.621 M 66.501 M 59.356 M 61.450 M 56.668 M
    -8.99% -4.92% -0.87% 6.20% -10.74% 3.53% -7.78%  
Operating income -37.261 M -66.437 M -14.784 M -62.556 M -66.474 M -59.331 M -61.437 M -56.665 M
Ebit -37.261 M -66.437 M -14.784 M -62.556 M -66.474 M -59.039 M -59.508 M -55.575 M
Pretax income -36.323 M -70.254 M -8.397 M -66.959 M -63.890 M -50.853 M -52.930 M -60.667 M
    93.41% -88.05% 697.42% -4.58% -20.41% 4.08% 14.62%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -36.323 M -70.254 M -8.397 M -66.959 M -63.890 M -50.853 M -52.930 M -60.667 M
    -93.41% 88.05% -697.42% 4.58% 20.41% -4.08% -14.62%  
Net income -36.323 M -70.254 M -8.397 M -66.959 M -63.890 M -50.853 M -52.930 M -60.667 M
    -93.41% 88.05% -697.42% 4.58% 20.41% -4.08% -14.62%